India
· Delayed Price · Currency is INR Mukka Proteins Statistics
Total Valuation
Mukka Proteins has a market cap or net worth of INR 11.83 billion. The enterprise value is 16.19 billion.
| Market Cap | 11.83B |
| Enterprise Value | 16.19B |
Important Dates
The next estimated earnings date is Thursday, February 13, 2025.
| Earnings Date | Feb 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Mukka Proteins has 300.00 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 300.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -1.56% |
| Owned by Insiders (%) | 73.33% |
| Owned by Institutions (%) | 9.08% |
| Float | 80.00M |
Valuation Ratios
The trailing PE ratio is 23.63.
| PE Ratio | 23.63 |
| Forward PE | n/a |
| PS Ratio | 0.95 |
| PB Ratio | 2.94 |
| P/TBV Ratio | 3.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.79, with an EV/FCF ratio of -6.20.
| EV / Earnings | 36.54 |
| EV / Sales | 1.48 |
| EV / EBITDA | 19.79 |
| EV / EBIT | 23.58 |
| EV / FCF | -6.20 |
Financial Position
The company has a current ratio of 1.60, with a Debt / Equity ratio of 1.03.
| Current Ratio | 1.60 |
| Quick Ratio | 0.28 |
| Debt / Equity | 1.03 |
| Debt / EBITDA | 5.46 |
| Debt / FCF | -1.63 |
| Interest Coverage | 2.76 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 26.51M |
| Profits Per Employee | 1.07M |
| Employee Count | 414 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 41.76 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 41.44 |
| Average Volume (20 Days) | 69,641 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Mukka Proteins had revenue of INR 10.97 billion and earned 443.06 million in profits. Earnings per share was 1.67.
| Revenue | 10.97B |
| Gross Profit | 2.07B |
| Operating Income | 648.05M |
| Pretax Income | 517.47M |
| Net Income | 443.06M |
| EBITDA | 765.66M |
| EBIT | 648.05M |
| Earnings Per Share (EPS) | 1.67 |
Balance Sheet
The company has 52.02 million in cash and 4.26 billion in debt, giving a net cash position of -4.21 billion or -14.03 per share.
| Cash & Cash Equivalents | 52.02M |
| Total Debt | 4.26B |
| Net Cash | -4.21B |
| Net Cash Per Share | -14.03 |
| Equity (Book Value) | 4.14B |
| Book Value Per Share | 13.42 |
| Working Capital | 2.85B |
Cash Flow
In the last 12 months, operating cash flow was -2.43 billion and capital expenditures -181.48 million, giving a free cash flow of -2.61 billion.
| Operating Cash Flow | -2.43B |
| Capital Expenditures | -181.48M |
| Free Cash Flow | -2.61B |
| FCF Per Share | -8.70 |
Margins
Gross margin is 18.85%, with operating and profit margins of 5.91% and 4.04%.
| Gross Margin | 18.85% |
| Operating Margin | 5.91% |
| Pretax Margin | 4.72% |
| Profit Margin | 4.04% |
| EBITDA Margin | 6.98% |
| EBIT Margin | 5.91% |
| FCF Margin | n/a |
Dividends & Yields
Mukka Proteins does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 4.23% |
| FCF Yield | -22.07% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |